Nasdaq: RNA
Atrium Therapeutics insiders
The officers, directors and 10% owners of Atrium Therapeutics, Inc. who hold the most stock, valued at the live RNA price.
$6.98
RNA today +$340K (+5.12%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their RNA stock
- $82K
Insiders by value of RNA holdings
SEC ownership page| # | Insider | Role | Shares | Value | Overall rank |
|---|---|---|---|---|---|
| 1 | Troy E. Wilson | Director | 11,731 | $82K | 8690th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Atrium Therapeutics; see each profile for the filing.